<rss version="2.0" xmlns:a10="http://www.w3.org/2005/Atom"><channel><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link><description>RSC - RSC Med. Chem. latest articles</description><copyright>Copyright (c)  The Royal Society of Chemistry</copyright><lastBuildDate>Tue, 09 Jun 2026 19:01:37 Z</lastBuildDate><category>RSC - RSC Med. Chem. latest articles</category><image><url>http://pubs.rsc.org/content/NewImages/rsc_publishing_logo.gif</url><title>RSC - RSC Med. Chem. latest articles</title><link>http://pubs.rsc.org/en/Journals/Journal/MD</link></image><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00119J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00119J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00119J</link><title>Targeting DNA-PK: medicinal chemistry insights into small-molecule inhibitor discovery and optimisation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00119J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00119J, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Elle Watson, Jack R. R. Hutchinson, Suzannah J. Harnor, Luke Gaughan, Celine Cano&lt;br/&gt;Since Wortmannin's discovery, DNA-PK inhibitors have expanded to optimised scaffolds, including chromen-4-ones (&lt;em&gt;e.g.&lt;/em&gt; NU5455) and purinones (&lt;em&gt;e.g.&lt;/em&gt; AZD7648). This review covers their synthesis and pharmacology from early hits to clinical candidates.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-08T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Elle Watson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jack R. R. Hutchinson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suzannah J. Harnor</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Luke Gaughan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Celine Cano</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00223D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00223D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00223D</link><title>Recent advances in piperine and its derivatives as potential anticancer agents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00223D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00223D, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Qi-Hua Yu, Zhiyan Liu, Jiazheng Liu, Li-Ping Bai&lt;br/&gt;This review identified piperine as a promising anticancer agent, demonstrating that the structural modification of its amide region can significantly improve the anticancer activity.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-21T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Qi-Hua Yu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhiyan Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiazheng Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Li-Ping Bai</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00300A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00300A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00300A</link><title>Triarylphosphonium-conjugated Sn(IV)-porphyrins for antimicrobial photodynamic therapy: impact of substituents on lipophilicity, aggregation, and photoantibacterial activity</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00300A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00300A, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Gayathri MP, Nandhakumar Muruganandam, Sutharsan Govindarajan, Balaji Babu&lt;br/&gt;Antimicrobial photodynamic therapy is an effective approach to counteract bacterial infections that are not possible to be treated through antibiotics.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-19T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Gayathri MP</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nandhakumar Muruganandam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sutharsan Govindarajan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Balaji Babu</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00265J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00265J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00265J</link><title>Novel Hydroxytyrosol Esters as Potential Anti-Amyloid and Neuroprotective Agents for Alzheimer's Disease</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00265J, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Ioanna  Kalpaktsi, Anthi Panara, Barbara  Mavroidi, Garcia  Niforos, Amalia D Kalampaliki, Ioanna C Vlachogianni, Eleftheria A Georgiou, Elizabeth Fragopoulou, Anthony Tarbopoulos, AL Skaltsounis, Maria Pelecanou, K Palikaras, Evagelos Gikas, Ioannis  K.  Kostakis&lt;br/&gt;Alzheimer's disease (AD) is associated with the aggregation of β-amyloid (Aβ) peptides and oxidative stress, two interconnected processes that contribute to neuronal dysfunction and cognitive decline. Natural polyphenols such as...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-04T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Ioanna  Kalpaktsi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anthi Panara</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Barbara  Mavroidi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Garcia  Niforos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amalia D Kalampaliki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ioanna C Vlachogianni</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eleftheria A Georgiou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Elizabeth Fragopoulou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anthony Tarbopoulos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">AL Skaltsounis</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maria Pelecanou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">K Palikaras</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Evagelos Gikas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ioannis  K.  Kostakis</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00158K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00158K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00158K</link><title>Synthetic routes towards antiviral agents from the houttuynoid family: structure–activity relationships and antiviral efficacy against herpes simplex virus type 1</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00158K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00158K, Review Article&lt;/div&gt;&lt;div&gt;Adarsh Krishna T. P, Ajeesh Krishna T. P, Reshma Rajan, Laxman Kota, Prasobh K. Mohan&lt;br/&gt;This review delineates the total synthesis of houttuynoids, highlighting a diverse chemical toolkit and their structure–activity relationships (SARs) and antiviral efficacy.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-18T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Adarsh Krishna T. P</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ajeesh Krishna T. P</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Reshma Rajan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Laxman Kota</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Prasobh K. Mohan</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00278A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00278A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00278A</link><title>Synthesis, molecular modelling and evaluation of (-)-isopulegolbased 2,4-diaminopyrimidines as promising Aurora kinase inhibitors</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00278A, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Tam Minh Le, Nikoletta  Szemerédi, Gabriella Spengler, Minh Canh  Nguyen, Huynh Nguyen Khanh  Tran , Khac-Minh Thai, Zsolt Szakonyi&lt;br/&gt;A library of (-)-isopulegol based 2,4-diaminopyrimidines was prepared from commercially available (-)-isopulegol. Aminodiols, derived from (-)-isopulegol according to literature methods, were added to 5-substituted 2,4dichloropyrimidines, then the resulting products were...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-03T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Tam Minh Le</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nikoletta  Szemerédi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gabriella Spengler</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Minh Canh  Nguyen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huynh Nguyen Khanh  Tran </creator><creator xmlns="http://purl.org/dc/elements/1.1/">Khac-Minh Thai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zsolt Szakonyi</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00275G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00275G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00275G</link><title>Novel Urea- and Piperazine-Functionalized Alepterolic Acid Derivatives: Synthesis, Anticancer Activity, and Mechanism of Action</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00275G, Research Article&lt;/div&gt;&lt;div&gt;Binbin Zhang, Yating Jia, Siyu Qiu, Yanchun Sun, Lian Ma, Peixin Wang, Zixuan Tong, Fengjiao Wang, Guozheng Huang, Jianguo Cao&lt;br/&gt;Lung cancer remains the leading cause of both cancer incidence and mortality worldwide, rendering it a primary focus in oncology research. This pressing global health challenge has created an urgent...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-03T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Binbin Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yating Jia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Siyu Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanchun Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lian Ma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Peixin Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zixuan Tong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fengjiao Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Guozheng Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jianguo Cao</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00230G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00230G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00230G</link><title>A Bakuchiol-Linked Tetrazole Exhibits Narrow-spectrum Activity Against Streptococcus pneumoniae</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00230G, Research Article&lt;/div&gt;&lt;div&gt;Neha  Sengar, Vidyadhar  Pratap, Tuhin Sarkar, Vishnu Kriplani, Astha Gupta, Sanjay Mandal, Prasad V. Bharatam, Dulal Panda, Inder Pal Singh&lt;br/&gt;Natural product-based amphiphilic phenolic terpenoid antimicrobial agents were rationally designed by integrating the meroterpenoid bakuchiol with a tetrazole moiety through a fragment-based drug design strategy. A library of 30 bakuchiol-linked...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-02T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Neha  Sengar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vidyadhar  Pratap</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tuhin Sarkar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishnu Kriplani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Astha Gupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sanjay Mandal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Prasad V. Bharatam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dulal Panda</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Inder Pal Singh</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00211K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00211K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00211K</link><title>Identification and structure–activity relationship analysis of minimal fusion inhibitors targeting measles virus F protein</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00211K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00211K, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Kazuya Kobayashi, Yuki Yamaguchi, Mizuki Itahara, Kazushige Hirata, Keisuke Aoki, Naoya Iwamoto, Hironori Hayashi, Eiichi Kodama, Shinya Oishi&lt;br/&gt;Optimization of a measles virus HR2-derived fusion inhibitor yielded a short peptide with potent antiviral activity and revealed key residues governing interactions with HR1.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-13T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Kazuya Kobayashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuki Yamaguchi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mizuki Itahara</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kazushige Hirata</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Keisuke Aoki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Naoya Iwamoto</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hironori Hayashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Eiichi Kodama</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shinya Oishi</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00285D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00285D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00285D</link><title>3-Hydroxypyrimidine-2,4-dione derivatives as monkeypox virus resolvase (Mpr) inhibitors</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00285D, Research Article&lt;/div&gt;&lt;div&gt;Muhammad Syafiq  Bin Shahari, Jacob P Mahoney, Ziyue  Wang, Anil  Pant, Ajit  Jagtap, Roshan  Katekar, Jiashu Xie, Zhilong  Yang, Zhengqiang Wang&lt;br/&gt;Holliday junction resolvase plays an important role in poxvirus genome replication and viral maturation. Recently, we developed the first in vitro assay measuring the activity of orthopoxvirus resolvases, particularly monkeypox...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-06-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Muhammad Syafiq  Bin Shahari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jacob P Mahoney</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ziyue  Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anil  Pant</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ajit  Jagtap</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Roshan  Katekar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiashu Xie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhilong  Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhengqiang Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00259E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00259E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00259E</link><title>Structure–activity relationships in a series of dihydrouracil–JQ1 conjugates: discovery of highly potent BRD4 degraders</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00259E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00259E, Research Article&lt;/div&gt;&lt;div&gt;Oleh Shyshlyk, Vladyslav Stadnichenko, Oleksandr Diachenko, Iryna Chernysh, Anna Beshtynarska, Diana Alieksieieva, Diana Khotinets, Oleksii Oleksiak, Dmytro Lesyk, Yelyzaveta Yeremenko, Angelina V. Biitseva, Petro Borysko, Volodymyr Yarmolchuk, Ganna M. Tolstanova, Oleksandr O. Grygorenko&lt;br/&gt;Comprehensive SAR studies in a series of phenyl dihydrouracil (PDHU)-derived PROTACs led to the discovery of novel nanomolar BRD4 degraders.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-07T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Oleh Shyshlyk</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vladyslav Stadnichenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Oleksandr Diachenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Iryna Chernysh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Beshtynarska</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Diana Alieksieieva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Diana Khotinets</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Oleksii Oleksiak</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dmytro Lesyk</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yelyzaveta Yeremenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Angelina V. Biitseva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Petro Borysko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Volodymyr Yarmolchuk</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ganna M. Tolstanova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Oleksandr O. Grygorenko</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00204H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00204H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00204H</link><title>Bismuth drug as antibiotic adjuvant to inhibit biofilm formation via a dual mechanism</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00204H, Research Article&lt;/div&gt;&lt;div&gt;Jingru Li, Peng Gao, Richard Yi-Tsun Kao, Hongyan Li, Hongzhe Sun&lt;br/&gt;Burkholderia cepacia (B. cepacia) exhibits intrinsic resistance to many conventional antibiotics. A key factor contributing to this resistance is its ability to form biofilms, which hinder antibiotic penetration and make...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jingru Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Peng Gao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Richard Yi-Tsun Kao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongyan Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hongzhe Sun</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00178E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00178E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00178E</link><title>Solvent and Catalyst-Free Mechanochemical Synthesis of Indenyl-Derived Thiazolone imine, Thiazolidin-4-one and Thiazolidin-4-ol Hybrids: Anticancer Evaluation and Molecular Modeling Studies</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00178E, Research Article&lt;/div&gt;&lt;div&gt;Sanket Shantaram Mohite, Vikas Madhukar Bangade, Ambareen Shaikh, Bhushan Bhagwantrao Popatkar&lt;br/&gt;To shed light on the significance of indenyl-derived thiazole derivatives in the advancement of cancer medication and to contribute to therapeutic innovation, we wish to disclose a facile, effective and...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Sanket Shantaram Mohite</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vikas Madhukar Bangade</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ambareen Shaikh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bhushan Bhagwantrao Popatkar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00221H</link><title>Synthesis-guided design and discovery of alkylated indoles with antibacterial activity against MRSA</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00221H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00221H, Research Article&lt;/div&gt;&lt;div&gt;Auqib Rashid, Vishwani Jamwal, Bilal A. Bhat, Kuljit Singh, Showkat Rashid&lt;br/&gt;This research work presents a framework for rational design, synthesis, and detailed biological evaluation of a series of C-3 alkylated indole derivatives as potential antibacterial agents against methicillin-resistant &lt;em&gt;Staphylococcus aureus&lt;/em&gt; (MRSA).&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-21T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Auqib Rashid</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishwani Jamwal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bilal A. Bhat</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kuljit Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Showkat Rashid</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00226A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00226A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00226A</link><title>Investigation of 2,3-diaryl-1,3-thiazolidin-4-ones as promising agents for reducing lipid accumulation in liver cells through AMPK activation: synthesis, in vitro, in silico and lipidomic studies</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00226A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00226A, Research Article&lt;/div&gt;&lt;div&gt;Arnatchai Maiuthed, Nichawadee Sandech, Meng Chieh Yang, Sucheewin Krobthong, Pattarawit Rukthong, Kittisak Sripha, Witcha Imaram, Chaiyawat Aonsri&lt;br/&gt;A series of 2,3-diaryl-1,3-thiazolidin-4-ones was synthesized and identified as promising AMP-activated protein kinase (AMPK) activators with potential lipid-lowering activity.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-11T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Arnatchai Maiuthed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nichawadee Sandech</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meng Chieh Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sucheewin Krobthong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pattarawit Rukthong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kittisak Sripha</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Witcha Imaram</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chaiyawat Aonsri</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00096G</link><title>Light-controlled inhibition of Gram-positive bacteria by photoswitchable amphiphilic lipids (PALs)</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00096G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00096G, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Guilherme F. S. Fernandes, Seong-Heun Kim, Charlotte K. Hind, Jessica Furner-Pardoe, Janis Romanopulos, Christian D. Lorenz, A. James Mason, J. Mark Sutton, Daniele Castagnolo&lt;br/&gt;Photoswitchable amphiphilic lipids (PALs) enable reversible light-controlled inhibition of Gram-positive bacteria. Azobenzene photoisomerization modulates membrane insertion, switching antibacterial activity on or off depending on alkyl chain length.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Guilherme F. S. Fernandes</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Seong-Heun Kim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlotte K. Hind</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jessica Furner-Pardoe</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Janis Romanopulos</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christian D. Lorenz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">A. James Mason</creator><creator xmlns="http://purl.org/dc/elements/1.1/">J. Mark Sutton</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daniele Castagnolo</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00800J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00800J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00800J</link><title>Design, synthesis, and anticancer evaluation of novel pyrrole–pyrazoline/chalcone hybrids: in vitro and computational insights into EGFR inhibition</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00800J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2667-2691&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00800J, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Mansour S. Alturki, Marwa F. Ahmed, Abdulaziz H. Al Khzem, Mohamed S. Gomaa, Mohammad Sarafroz, Nada Tawfeeq, Mashael M. Alharbi, Abdulaziz K. Al Mouslem, Mohammed F. Aldawsari, Wajin R. Alruwili, Shah Alam Khan, Radwan El-Haggar, Atiah H. Almalki&lt;br/&gt;Design, synthesis, and biological evaluation of pyrazoline–pyrrole hybrids led to the identification of compound &lt;strong&gt;6b&lt;/strong&gt; as a potent EGFR inhibitor with significant antiproliferative activity against MCF-7 cells.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-27T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mansour S. Alturki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marwa F. Ahmed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulaziz H. Al Khzem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed S. Gomaa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohammad Sarafroz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nada Tawfeeq</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mashael M. Alharbi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulaziz K. Al Mouslem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohammed F. Aldawsari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wajin R. Alruwili</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shah Alam Khan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Radwan El-Haggar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Atiah H. Almalki</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01082A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01082A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01082A</link><title>Lead optimization of 5jc21 (CG13250), a quinolin-2(1H)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteins</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01082A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2630-2643&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01082A, Research Article&lt;/div&gt;&lt;div&gt;Jay Chauhan, Sarah Pogash, Makoto Yoshioka, Mithun Raje, Daniel Van Eker, Jeffrey W. Strovel, Steven Fletcher&lt;br/&gt;4,6-Disubstituted quinolinones are potent BRD4 inhibitors.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Jay Chauhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sarah Pogash</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Makoto Yoshioka</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mithun Raje</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daniel Van Eker</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jeffrey W. Strovel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Steven Fletcher</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00022C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00022C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00022C</link><title>Pyrazole–triazole hybrids as kinase-triad inhibitors: a triple-target strategy for synergistic anticancer therapy</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00022C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2360-2386&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00022C, Research Article&lt;/div&gt;&lt;div&gt;Mahmoud S. Elkotamy, Mohamed K. Elgohary, Mariam M. Fakhry, Mohamed E. Albakri, Abdelrahman A. Naglah, Abdulrahman A. Almehizia, Ahmed M. Naglah, Mohamed Fares, Haytham O. Tawfik, Wagdy M. Eldehna, Hatem A. Abdel-Aziz&lt;br/&gt;The ongoing issue of drug resistance and the lack of specificity in existing cancer treatments highlight the necessity for innovative multi-target agents.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud S. Elkotamy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed K. Elgohary</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mariam M. Fakhry</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed E. Albakri</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdelrahman A. Naglah</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulrahman A. Almehizia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed M. Naglah</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed Fares</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haytham O. Tawfik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wagdy M. Eldehna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00115G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00115G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00115G</link><title>Diverse ring architectures of cyclic peptidomimetics targeting melanocortin receptors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00115G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2326-2346&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00115G, Review Article&lt;/div&gt;&lt;div&gt;Wenxiao K. Yue, Nicholas Barlow, Philip E. Thompson&lt;br/&gt;A review of the many types of macrocyclic melanocortin peptides. We show that there is a historical gap in the evaluation of these architectures in terms of their influence upon potency, selectivity and pharmacokinetics.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-21T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Wenxiao K. Yue</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nicholas Barlow</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Philip E. Thompson</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01147G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01147G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01147G</link><title>Structure-based design of potent pyrazolo[1,5-a]pyrimidine CDK4/6 inhibitors: biological evaluation and computational validation</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01147G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2566-2587&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01147G, Research Article&lt;/div&gt;&lt;div&gt;Faizah A. Binjubair, Mahmoud S. Elkotamy, Amr A. Mattar, Bjad K. Almutairy, Sara T. Al-Rashood, Mohamed M. Eldesouki, Jalloul Bouajila, Hatem A. Abdel-Aziz, Mariam M. Fakhry&lt;br/&gt;Structure-based design yielded potent CDK4/6 inhibitor &lt;strong&gt;19i&lt;/strong&gt;, inducing G1 cell-cycle arrest and apoptosis in HCT-116 cells, supported by enzymatic inhibition and molecular docking/dynamics studies.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-20T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Faizah A. Binjubair</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud S. Elkotamy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amr A. Mattar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bjad K. Almutairy</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sara T. Al-Rashood</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed M. Eldesouki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jalloul Bouajila</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mariam M. Fakhry</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00019C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00019C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00019C</link><title>Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00019C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2549-2565&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00019C, Research Article&lt;/div&gt;&lt;div&gt;Dong Xu, Wenxiu Weng, Huining Cao, Chao Zhang, Yudi Zhang, Yan Li, Junhai Xiao, Hua Xie, Jialin Guo, Guoliang Chen&lt;br/&gt;Structure-based rational design yielded novel potent BCAT2 inhibitors &lt;strong&gt;C10&lt;/strong&gt; (IC&lt;small&gt;&lt;sub&gt;50&lt;/sub&gt;&lt;/small&gt; = 44 nM) and &lt;strong&gt;C11&lt;/strong&gt; (IC&lt;small&gt;&lt;sub&gt;50&lt;/sub&gt;&lt;/small&gt; = 54 nM), which exhibit 8–10-fold selectivity over BCAT1 and form stable, key interactions within the BCAT2 active pocket.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-20T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Dong Xu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wenxiu Weng</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huining Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chao Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yudi Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Junhai Xiao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hua Xie</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jialin Guo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Guoliang Chen</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00819K</link><title>Decoding the association of polycystic ovary syndrome with metabolic-associated fatty liver: insights into CK18 and LC3II/ATG7/P62 autophagy axis and adjunct therapeutics of metformin and levothyroxine</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00819K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2508-2537&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00819K, Research Article&lt;/div&gt;&lt;div&gt;Sameeah Mejbel Hamad Algenabi, Anwar Nather Seiwan, Maha Hussein Hashem Sabra, Doaa I. Mohamed, Lobna Fouad Abd ElAziz Bassyouni, Dalia Alaa El-Din Aly El-Waseef, Samar F. Ezzat, Omnyah A. El-Kharashi, Hanaa F. Abd El-Kareem, Hyfa A. Alzahrani, Fawzyah Obeedallah Albaldi, Ahmed Shokry Elharoun, Mansour Altayyar, Amal Fahmy Dawood, Hebatallah H. Abo Nahas, Ahmed Abdel-Salam M. Elmelegy&lt;br/&gt;Metformin–levothyroxine synergistically treats PCOS-MAFLD. Reduced body/liver weight, ALT/AST/TSH/lipids, testosterone/LH/HOMA-IR. Increased estradiol. Suppressed autophagy (LC3II/ATG7/p62/CK18) and improved histology.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-13T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Sameeah Mejbel Hamad Algenabi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anwar Nather Seiwan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Maha Hussein Hashem Sabra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Doaa I. Mohamed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lobna Fouad Abd ElAziz Bassyouni</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dalia Alaa El-Din Aly El-Waseef</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samar F. Ezzat</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Omnyah A. El-Kharashi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hanaa F. Abd El-Kareem</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hyfa A. Alzahrani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fawzyah Obeedallah Albaldi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Shokry Elharoun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mansour Altayyar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amal Fahmy Dawood</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hebatallah H. Abo Nahas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Abdel-Salam M. Elmelegy</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00097E</link><title>Phenoxyacetic acid scaffold as a platform for dual anticonvulsant and anti-inflammatory drug design</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00097E" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2486-2507&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00097E, Research Article&lt;/div&gt;&lt;div&gt;Mohamed K. Elgohary, Mahmoud Abdelrahman Alkabbani, Aya Mohamed Ahmed Ibrahim, Ahmed Elsonbaty, Mayada H. Mohamed, Abdulrahman A. Almehizia, Ahmed M. Naglah, Mohamed Fares, Hatem A. Abdel-Aziz&lt;br/&gt;Neuroinflammation is increasingly recognized as a critical contributor to epileptogenesis and antiepileptic drug resistance, emphasizing the need for multi-target therapeutic strategies.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-10T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed K. Elgohary</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahmoud Abdelrahman Alkabbani</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Aya Mohamed Ahmed Ibrahim</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed Elsonbaty</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mayada H. Mohamed</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Abdulrahman A. Almehizia</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ahmed M. Naglah</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohamed Fares</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hatem A. Abdel-Aziz</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00088F</link><title>Beyond acrylamide: a structure-guided investigation of covalent warheads in the development of CDK7 inhibitors</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00088F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2692-2713&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00088F, Research Article&lt;/div&gt;&lt;div&gt;Yu Cao, Yiqing Huang, Yunlong Pan, Jialuo Mao, Lixin Gao, Jiankang Zhang, Huajian Zhu, Shourong Liu, Rangxiao Zhuang, Yang Liu, Yubo Zhou, Jiaan Shao&lt;br/&gt;To achieve covalent CDK7 inhibitors with superior antiproliferative activity and enhanced selectivity, we designed and synthesized a series of covalent CDK7 inhibitors bearing diverse warheads based on the THZ1 scaffold.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-10T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yu Cao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yiqing Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunlong Pan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jialuo Mao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lixin Gao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiankang Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Huajian Zhu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shourong Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rangxiao Zhuang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yang Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yubo Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiaan Shao</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01095K</link><title>Recent advances towards BACE1 drug discovery and therapeutics design</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01095K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2306-2325&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01095K, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Saim Imran, Meera Patel, Meissam Noroozifar, Kagan Kerman&lt;br/&gt;We explored the latest developments in modulators, antibody therapy, and gene therapy targeting β-site amyloid precursor protein cleaving enzyme 1 (BACE1) to combat Alzheimer's disease.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-09T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Saim Imran</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meera Patel</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Meissam Noroozifar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kagan Kerman</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00217J</link><title>Bicyclic monoterpenoid-based orthopoxvirus inhibitors: design, synthesis, and biological assessment of a novel amide series</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00217J" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2605-2629&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00217J, Research Article&lt;/div&gt;&lt;div&gt;Serafim A. Tishchenko, Anastasiya S. Sokolova, Valeriya V. Samsonova, Julia G. Pushkareva, Nikolay I. Bormotov, Ivan A. Moskalev, Daria. E. Solomina, Artem D. Rogachev, Alina V. Fatyanova, Sophia S. Borisevich, Olga I. Yarovaya, Olga A. Serova, Alena S. Ovchinnikova, Alexander A. Sergeev, Larisa N. Shishkina, Artemiy A. Sergeev, Alexander P. Agafonov, Nariman F. Salakhutdinov&lt;br/&gt;This study reports the design, synthesis, and comprehensive biological evaluation of a new class of orthopoxvirus inhibitors utilizing natural bicyclic monoterpenoid scaffolds as strategic replacements for synthetic polycyclic cores.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-09T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Serafim A. Tishchenko</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anastasiya S. Sokolova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Valeriya V. Samsonova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Julia G. Pushkareva</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nikolay I. Bormotov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ivan A. Moskalev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daria. E. Solomina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Artem D. Rogachev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alina V. Fatyanova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sophia S. Borisevich</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Olga I. Yarovaya</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Olga A. Serova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alena S. Ovchinnikova</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander A. Sergeev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Larisa N. Shishkina</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Artemiy A. Sergeev</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alexander P. Agafonov</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nariman F. Salakhutdinov</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00165C</link><title>Quinoline/thiazole compounds as selective acetylcholinesterase inhibitors: synthesis and biological assessment</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00165C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2404-2412&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00165C, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Berkant Kurban, Derya Osmaniye, Serkan Levent, Yusuf Özkay, Zafer Asım Kaplancıklı&lt;br/&gt;Acetylcholine (ACh), acetylcholinesterase enzyme (AChE), and AChE inhibition are of great importance in the treatment of neurodegenerative diseases.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-07T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Berkant Kurban</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Derya Osmaniye</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Serkan Levent</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yusuf Özkay</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zafer Asım Kaplancıklı</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01173F</link><title>Redefining the role of the thiol-based agent N-acetylcysteine in human health and disease and elucidating potential advantages of its amide derivative</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01173F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2183-2196&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01173F, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Hui-Qi Qu, Charlly Kao, Hakon Hakonarson&lt;br/&gt;&lt;em&gt;N&lt;/em&gt;-Acetylcysteine amide (NACA) reduces polarity and ionization relative to NAC, improving membrane permeability and intracellular exposure while preserving thiol-mediated redox activity and glutathione support.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-01T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Hui-Qi Qu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Charlly Kao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hakon Hakonarson</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01001B</link><title>Design, synthesis, and biological evaluation of quinoline derivatives as dual-target inhibitors of chitin synthase and glucosamine-6-phosphate synthase</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01001B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2588-2604&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01001B, Research Article&lt;/div&gt;&lt;div&gt;Nan Wang, Lige Liu, Tao Liu, Hong Luo, Yan Long, Xinlong Yang, Youli Zhang, Qinggang Ji&lt;br/&gt;This study designed and synthesized a series of glycine methyl ester quinoline derivatives as dual-target inhibitors of CHS and GlmS, followed by biological evaluation including enzyme inhibition assays and &lt;em&gt;in vitro&lt;/em&gt; antifungal activity testing.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-26T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lige Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Tao Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hong Luo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yan Long</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xinlong Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Youli Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qinggang Ji</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00148C</link><title>Novel zerumbone-amide-triazole hybrids as potential NF-κB pathway inhibitors: design, synthesis, cytotoxicity evaluation, computational studies, and mechanistic insights</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00148C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2387-2403&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00148C, Research Article&lt;/div&gt;&lt;div&gt;Pham The Chinh, Pham Thi Tham, Vu Thi Lien, Dao Thi Nhung, Le Thi Thuy Loan, Khieu Thi Tam, Vu Tuan Kien, Cao Thanh Hai, Phan Thanh Phuong, Truong Thi Thao, Vuong Truong Xuan, Le Thi Lien&lt;br/&gt;A series of fifteen novel zerumbone-amide-triazole hybrids &lt;strong&gt;12a–i&lt;/strong&gt; and &lt;strong&gt;15a–f&lt;/strong&gt; were successfully designed and synthesized from azazerumbone II (&lt;strong&gt;2&lt;/strong&gt;) &lt;em&gt;via&lt;/em&gt; click reaction.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-26T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Pham The Chinh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Pham Thi Tham</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Thi Lien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dao Thi Nhung</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Le Thi Thuy Loan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Khieu Thi Tam</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Tuan Kien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Cao Thanh Hai</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Phan Thanh Phuong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Truong Thi Thao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vuong Truong Xuan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Le Thi Lien</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00026F</link><title>D-Galactose-conjugated pyrimidine thioureas as potent antimicrobial agents: rapid green synthesis, structure–activity relationships and molecular modelling</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00026F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2644-2666&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00026F, Research Article&lt;/div&gt;&lt;div&gt;Nguyen Dinh Thanh, Vu Ngoc Toan, Ngo Hong Anh Thu, Nguyen Minh Tri, Duong Ngoc Toan, Hoang Thi Kim Van&lt;br/&gt;&lt;small&gt;D&lt;/small&gt;-Galactose–pyrimidine thioureas were synthesized &lt;em&gt;via&lt;/em&gt; a recyclable ionic liquid–microwave method in high yields. Several derivatives showed broad-spectrum antimicrobial activity, and docking with ADMET predicted strong binding and drug-like properties.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-25T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nguyen Dinh Thanh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vu Ngoc Toan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ngo Hong Anh Thu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Nguyen Minh Tri</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Duong Ngoc Toan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hoang Thi Kim Van</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01046B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01046B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01046B</link><title>Design, synthesis and biological evaluation of benzoyl hydrazone derivatives as anticancer agents inducing ROS-associated mitochondrial apoptosis</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01046B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2413-2427&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01046B, Research Article&lt;/div&gt;&lt;div&gt;Rongbin Wei, Xin Wang, Yamin Ding, Suting Zhu, Richmond Kwame Frimpong Asiedu, Muzi Li, Haitao Qian, Yifei Gu, Bailing Jiang&lt;br/&gt;Compound &lt;strong&gt;Q-11&lt;/strong&gt; shows potent nanomolar antiproliferative activity in gastric cancer cells and induces ROS accumulation, mitochondrial dysfunction and cytoskeletal disruption.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-23T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rongbin Wei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xin Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yamin Ding</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suting Zhu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Richmond Kwame Frimpong Asiedu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Muzi Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haitao Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yifei Gu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Bailing Jiang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00084C</link><title>Beyond infection control: exploring the therapeutic potential of antimicrobials in oncology and their synthetic perspectives</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00084C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2270-2305&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00084C, Review Article&lt;/div&gt;&lt;div&gt;Rahul Kumar, Mohd Yeshab Ansari&lt;br/&gt;This review explores the burgeoning potential of antimicrobial agents in oncology, highlighting their roles in reducing infection-related mortality, enhancing therapeutic effectiveness, and improving the overall quality of life in cancer patients.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-18T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rahul Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mohd Yeshab Ansari</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00030D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00030D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00030D</link><title>Rational discovery of novel phenylindole-bisamide derivatives as potent P-glycoprotein inhibitors for cancer multidrug resistance</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00030D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2455-2472&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00030D, Research Article&lt;/div&gt;&lt;div&gt;Zhikun Yang, Jiajia Han, Yanhong Yang, Xue Yang, Yijing Du, Zimeng Huang, Leyi Ying, Xin Yu, Yi Hua, Qihao Wu, Xiaozhou Mou, Hong Wang&lt;br/&gt;P-gp-mediated MDR hinders cancer chemotherapy. Our phenylindole-bisamide &lt;strong&gt;l1&lt;/strong&gt; shows potent MDR reversal, low cytotoxicity, broad chemosensitization. It inhibits P-gp efflux and suppresses 3D tumor growth with doxorubicin, a promising P-gp inhibitor.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-09T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zhikun Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jiajia Han</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yanhong Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xue Yang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yijing Du</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zimeng Huang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Leyi Ying</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xin Yu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yi Hua</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Qihao Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiaozhou Mou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hong Wang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01109D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01109D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01109D</link><title>Exploration of a benzothiophene scaffold for use as adjuvants with β-lactam antibiotics against methicillin-resistant Staphylococcus aureus</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01109D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2444-2454&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01109D, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY-NC.png' alt='Creative Commons Licence' border='none'/&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by-nc/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution-NonCommercial 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Monica A. Stefaniak, Vijay S. Gondil, Emily P. Gillis, Ansley M. Nemeth, Allen G. Oliver, Roberta J. Melander, Paul M. Dunman, Christian Melander&lt;br/&gt;Rising antibiotic resistance coupled with diminishing investment in antibiotic development has led to limited treatment options for multi drug-resistant bacterial infections.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-05T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Monica A. Stefaniak</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vijay S. Gondil</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Emily P. Gillis</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ansley M. Nemeth</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Allen G. Oliver</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Roberta J. Melander</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paul M. Dunman</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Christian Melander</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00057F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00057F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00057F</link><title>Pharmacological landscape of carbolines: a holistic view</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00057F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2197-2269&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00057F, Review Article&lt;/div&gt;&lt;div&gt;Yao Zhang, Fule Wu, Muneeb Ur Rehman, Sihui Long&lt;br/&gt;This review comprehensively explores the design, synthesis, and pharmacological activities of carboline isomers reported between 2000 and 2025, with a particular emphasis on their key bioactivities, encompassing anticancer, neuroprotective, antiparasitic, and antimicrobial.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-02T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yao Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fule Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Muneeb Ur Rehman</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sihui Long</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00911A</link><title>Hypoxia-triggered dichloroacetate delivery with effective reversal of cancer cell reprogramming</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00911A" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2538-2548&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00911A, Research Article&lt;/div&gt;&lt;div&gt;Rensong Sun, Lei Wang, Ziang Liu, Hao Wu, Wanwan Wang, Yang Wang, Xiao Qian, Engin U. Akkaya&lt;br/&gt;The 3-methyl-2-nitroimidazole dichloroacetate derivative studied in this work is a prodrug version of dichloroacetate, and it is active at lower concentrations in hypoxic cell cultures and suppresses tumor progression significantly &lt;em&gt;in vivo&lt;/em&gt;.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-03-02T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rensong Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Lei Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ziang Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Hao Wu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Wanwan Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yang Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Xiao Qian</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Engin U. Akkaya</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00013D</link><title>Triclosan–isatin hybrids as potent anti-proliferative agents inducing S-phase arrest via DNA gyrase inhibition in triple-negative breast cancer</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00013D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2473-2485&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00013D, Research Article&lt;/div&gt;&lt;div&gt; Shekhar, Asif Raza, Sukhmanpreet kaur, Amit Anand, Arun K. Sharma, Vipan Kumar&lt;br/&gt;A series of 1&lt;em&gt;H&lt;/em&gt;-1,2,3-triazole-tethered TCS–isatin hybrid compounds were synthesized and evaluated for their antiproliferative activity against triple-negative breast cancer (TNBC).&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-24T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/"> Shekhar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Asif Raza</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sukhmanpreet kaur</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Amit Anand</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Arun K. Sharma</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vipan Kumar</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01141H"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01141H</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01141H</link><title>Introducing CLipPA lipid chemodiversity to enzymatically truncated polymyxin B: a soft drug strategy to combat Gram-negative pathogens</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01141H" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2347-2359&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01141H, Research Article&lt;/div&gt;&lt;div&gt;Tae-Ung Na, Yann O. Hermant, Andrew Siow, Jeremy G. Owen, Susanna T. S. Chan, Gavin F. Painter, Cameron C. Hanna, Zillah Daysh, Beatrix L. Goggin, Jane R. Allison, Veronika Sander, Alan J. Davidson, Georgia Campbell, Scott A. Ferguson, Gregory M. Cook, Paul W. R. Harris, Margaret A. Brimble, Alan J. Cameron&lt;br/&gt;An efficient strategy to tune the activity and stability of semi-synthetic lipopeptides is presented, enabled by the CLipPA thiol–ene reaction.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-02-06T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Tae-Ung Na</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yann O. Hermant</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Andrew Siow</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jeremy G. Owen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Susanna T. S. Chan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gavin F. Painter</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Cameron C. Hanna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zillah Daysh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Beatrix L. Goggin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jane R. Allison</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Veronika Sander</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alan J. Davidson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Georgia Campbell</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Scott A. Ferguson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Gregory M. Cook</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Paul W. R. Harris</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Margaret A. Brimble</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Alan J. Cameron</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00900F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00900F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD00900F</link><title>From bolinaquinone, a marine hydroxyquinone sesquiterpene, to naphthoquinones with clathrin inhibitory effects</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD00900F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, &lt;b&gt;17&lt;/b&gt;,2428-2443&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD00900F, Research Article&lt;/div&gt;&lt;div&gt;Nicholas S. O'Brien, Azadeh Ghods, Jing Xue, Mary J. Garson, Ken W. L. Yong, Jennette A. Sakoff, Jayne Glibert, Megan Chircop, Uwe Fink, Volker Haucke, Phillip J. Robinson, Adam McCluskey&lt;br/&gt;Bolinaquinone (&lt;strong&gt;1&lt;/strong&gt;) is cited as a clathrin inhibitor; applying a DFT approach, naphthoquinones with similar electronic properties were designed and shown to be potent inhibitors of the clathrin N-terminal domain–amphiphysin interaction, &lt;em&gt;e.g.&lt;/em&gt;&lt;strong&gt;23&lt;/strong&gt;.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2025-12-30T00:00:00Z</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nicholas S. O'Brien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Azadeh Ghods</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jing Xue</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mary J. Garson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ken W. L. Yong</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jennette A. Sakoff</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jayne Glibert</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Megan Chircop</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Uwe Fink</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Volker Haucke</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Phillip J. Robinson</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Adam McCluskey</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00193A"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00193A</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00193A</link><title>Design, synthesis, in-silico and in-vitro evaluation of Novel Complex Naphthalimide-Ciprofloxacin Hybrids as next-generation antimicrobial agents</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00193A, Research Article&lt;/div&gt;&lt;div&gt;Arunava Manna, Dharmendra  singh, Ankita Singh, Harikesh Kumar  Gupta, Sajida Banoo, Sumit Maurya, Vishwakarma Krishna Ramesh, Khushbu Khushbu, Ambrish Kumar, Jyoti Kumari, Avisek Mahapa, Shruti Trivedi, Rajnish  Kumar, Shashikala Verma &lt;br/&gt;A series of ciprofloxacin-naphthalimide hybrid drugs as novel antibacterial agents were synthesized and screened for their antibacterial property against gram-positive and gram-negative bacterial strains, including drug-resistant clinical isolates. Minimum inhibitory...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-26T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Arunava Manna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Dharmendra  singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ankita Singh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Harikesh Kumar  Gupta</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sajida Banoo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sumit Maurya</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Vishwakarma Krishna Ramesh</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Khushbu Khushbu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ambrish Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jyoti Kumari</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Avisek Mahapa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shruti Trivedi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rajnish  Kumar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shashikala Verma </creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01035G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01035G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01035G</link><title>Twenty Years of Quinazolines as Tubulin Polymerisation Inhibitors</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01035G, Review Article&lt;/div&gt;&lt;div&gt;Nicholas O'Brien, Adam McCluskey&lt;br/&gt;Over the past two decades, the quinazoline scaffold has emerged as a privileged framework in the development of small molecule tubulin polymerisation inhibitors. Here we map the chemical space of...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-25T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Nicholas O'Brien</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Adam McCluskey</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00108D"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00108D</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00108D</link><title>Computational approaches for flavivirus drug discovery: targeting structural and non-structural proteins</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00108D" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00108D, Review Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Mayasah Al-Nema, Mariana Manzano Rendeiro, Daniella Liao, Marwan Abdelmahmoud Abdelkarim Maki&lt;br/&gt;Schematic overview of an integrative computational pipeline for drug discovery.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Mayasah Al-Nema</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mariana Manzano Rendeiro</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Daniella Liao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Marwan Abdelmahmoud Abdelkarim Maki</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00132G</link><title>Regioselective triclocarban-catalyzed synthesis of spiroindeno- and spirooxindolo-pyrrolizidines with apoptosis induction in MCF-7 cells</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00132G" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00132G, Research Article&lt;/div&gt;&lt;div&gt;V. Rukyanaik, Samata Pradhan, Chandraiah Godugu, Srinu Tothadi, Kadiyam Rama Krishna, Ravinder Pawar, Srinivas Basavoju&lt;br/&gt;The design of new molecules from known structural motifs &lt;em&gt;via&lt;/em&gt; [3 + 2] cycloaddition is a widely used strategy in modern drug discovery.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-22T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">V. Rukyanaik</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Samata Pradhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Chandraiah Godugu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srinu Tothadi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Kadiyam Rama Krishna</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ravinder Pawar</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srinivas Basavoju</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00290K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00290K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00290K</link><title>Design, synthesis, and biological evaluation of novel SN38–sulfonamide conjugates as Topo I/CA IX dual inhibitors inducing ferroptosis in colorectal cancer</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00290K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00290K, Research Article&lt;/div&gt;&lt;div&gt;Xinyu Zhao, Anna Ye, Yujie Wang, Yeying Qiu, Shiyan Liu, Liyu Wei, Feng Qin, Ye Zhang, Rizhen Huang&lt;br/&gt;A series of novel SN38–sulfonamide conjugates were designed and synthesized as carbonic anhydrase IX (CA IX) and topoisomerase I (Topo I) dual inhibitors for colorectal cancer therapy.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-04T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Xinyu Zhao</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Anna Ye</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yujie Wang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yeying Qiu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shiyan Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Liyu Wei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Feng Qin</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ye Zhang</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Rizhen Huang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00286B"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00286B</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00286B</link><title>From scaffold to selectivity-medicinal insights of PRMT1 and PRMT4 inhibitors for epigenetic cancer therapy</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00286B" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00286B, Review Article&lt;/div&gt;&lt;div&gt;Kanchan Pal, Shivani Kasana, Balak Das Kurmi, Preeti Patel&lt;br/&gt;SAR and docking analysis indicate important structural determinants and binding interactions that promote Selective and Dual PRMT1 and PRMT4 inhibition, making them potentially useful as epigenetic targets in various cancer treatments.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-08T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Kanchan Pal</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shivani Kasana</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Balak Das Kurmi</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Preeti Patel</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00273K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00273K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00273K</link><title>Structure-activity relationship for calanthoside, a potential hairgrowth stimulant with an indole 2-S-,3-O-bis-glucoside structure. Part 1: Role of two glucoside moieties in promoting HFDPC proliferation</title><description>&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Accepted Manuscript&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00273K, Research Article&lt;/div&gt;&lt;div&gt;&lt;img  alt='Open Access' src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/open_access_blue.png' /&gt; Open Access&lt;/div&gt;&lt;div&gt;&lt;a rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window'&gt; &lt;img src='http://sod-a.rsc-cdn.org/pubs.rsc-uat.org/content/NewImages/CCBY.png' alt='Creative Commons Licence' border='none' /&gt;&lt;/a&gt;&amp;nbsp This article is licensed under a &lt;a text-decoration=none rel='license' href='http://creativecommons.org/licenses/by/3.0/' target='_blank' title='This link will open in a new browser window' &gt;Creative Commons Attribution 3.0 Unported Licence.&lt;/a&gt;&lt;/div&gt;&lt;div&gt;Riko  Suzuki, Katsuki Takashima, Yoshiaki  Mannse, Haruto  Nishikawa, Mina  Ashidate, Shinsuke Marumoto, Fumihiro Ishikawa, Toshio  Morikawa, Genzoh Tanabe&lt;br/&gt;The development of new and effective drugs for treating androgenetic alopecia (AGA) remains challenging. Minoxidil and finasteride, two drugs currently used to treat AGA, were originally developed for treating hypertension...&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-05-15T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Riko  Suzuki</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Katsuki Takashima</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yoshiaki  Mannse</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Haruto  Nishikawa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mina  Ashidate</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Shinsuke Marumoto</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fumihiro Ishikawa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Toshio  Morikawa</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Genzoh Tanabe</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00120C</link><title>Addressing multidrug-resistant bacterial infections with iridium-based theragnostic agents</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00120C" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00120C, Research Article&lt;/div&gt;&lt;div&gt;Rama Karn, Mahesmita Sahoo, Sayantani Biswas, Suravi Chauhan, Ajay Kumar Nag, Soham Basu, Srikanta Patra, Debasis Manna&lt;br/&gt;An amphiphilic iridium(&lt;small&gt;III&lt;/small&gt;) complex self-assembles into cationic nanoaggregates that disrupt bacterial membranes and facilitate selective fluorescence imaging, providing a promising theragnostic platform to combat antimicrobial resistance.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-24T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Rama Karn</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Mahesmita Sahoo</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Sayantani Biswas</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Suravi Chauhan</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Ajay Kumar Nag</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Soham Basu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Srikanta Patra</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Debasis Manna</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00063K"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00063K</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D6MD00063K</link><title>Histone deacetylase-based dual inhibitors: research progress focusing on non-small cell lung cancer therapy</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D6MD00063K" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D6MD00063K, Review Article&lt;/div&gt;&lt;div&gt;Zihao Liu, Zhiguang Yang&lt;br/&gt;HDAC dual-target inhibitors integrate epigenetic modulation with complementary pathway blockade, achieving synergistic antitumor effects in NSCLC by enhancing efficacy, overcoming drug resistance, and reducing toxicity.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-29T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Zihao Liu</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Zhiguang Yang</creator></item><item xml:base="http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F"><guid isPermaLink="true">http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F</guid><link>http://pubs.rsc.org/en/Content/ArticleLanding/2026/MD/D5MD01089F</link><title>Sulfone and sulfoxide-containing pharmaceuticals: targets, pharmacological properties and SAR studies</title><description>&lt;div&gt;&lt;p&gt;&lt;img align="center"  src="/services/images/RSCpubs.ePlatform.Service.FreeContent.ImageService.svc/ImageService/image/GA?id=D5MD01089F" /&gt;&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;i&gt;&lt;b&gt;RSC Med. Chem.&lt;/b&gt;&lt;/i&gt;, 2026, Advance Article&lt;br/&gt;&lt;b&gt;DOI&lt;/b&gt;: 10.1039/D5MD01089F, Review Article&lt;/div&gt;&lt;div&gt;Yiran Zhou, Jinqu Li, Yiou Mei, Yuzhu Chen, Fengxia Sun, Yunfei Du&lt;br/&gt;Numerous sulfone/sulfoxide-containing drugs are FDA-approved for clinical use, and these moieties remain of great interest. This review overviews these agents, focusing on their targets, activities, and SAR studies.&lt;br/&gt;To cite this article before page numbers are assigned, use the DOI form of citation above.&lt;br/&gt;The content of this RSS Feed (c) The Royal Society of Chemistry&lt;/div&gt;</description><a10:updated>2026-04-28T00:00:00+01:00</a10:updated><creator xmlns="http://purl.org/dc/elements/1.1/">Yiran Zhou</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Jinqu Li</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yiou Mei</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yuzhu Chen</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Fengxia Sun</creator><creator xmlns="http://purl.org/dc/elements/1.1/">Yunfei Du</creator></item></channel></rss>